Carbetocin Versus Oxytocin and Hemodynamic Effects
- Conditions
- Effects of; Anesthesia, in Pregnancy
- Interventions
- Registration Number
- NCT00977769
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.
- Detailed Description
Healthy pregnant women sheduled for elective cesarean section. Invasive hemodynmaic monitoring with LiDCO Plus.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 76
- Healthy pregnant women for planned cesarean section
- Bleeding disorders
- Placenta disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description carbetocin 100 µg carbetocin 100 µg Carbetocin injection, 100µg, single injection oxytocin 5 u oxytocin 5 u Oxytocin 5U, injection, single injection placebo (NaCl) placebo (NaCl) Saline single injection
- Primary Outcome Measures
Name Time Method Cardiac Output 2.5 minutes The relative change in CO from baseline at the time of delivery up to 2.5 minutes post delivery.
Arterial Blood Pressure 2.5 min The mean change in SAP compared with baseline at the time of delivery up to 2.5 minutes post delivery.
- Secondary Outcome Measures
Name Time Method Bleeding 120 minutes The calculated estimated blood loss from delivery until 2 h after intervention
Trial Locations
- Locations (2)
Division of Anesthesia and Intensive Care Medicine
🇳🇴Oslo, Norway
Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
🇳🇴Oslo, Norway